Business Trends– category –
-
China’s Prinano Achieves Mass Production of 8-inch Photonic Chips with Proprietary Nanoimprint Tech, Bypassing ASML Equipment, Reducing Cost by 10x, and Achieving Sub-10nm Resolution to Circumvent Export Controls
South China Morning Post China Overview Chinese startup Prinano announced successful mass production of photonic chips on 8-inch silicon wafers using its proprietary PL-AS vacuum air-cushion nanoimprint lithography (NIL) equipment, elimi... -
FDA Endorses ‘Prior Knowledge’ Use in Gene Therapy Development, Streamlining Review for AAV, Nanoparticle Delivery Systems, and Cell Therapies
Hogan Lovells USA Overview The U.S. Food and Drug Administration (FDA) issued guidance endorsing the use of 'Prior Knowledge' in the development of genome editing products, a policy expected to streamline drug development and review proc... -
First Graphene Acquires US-Based MITO Material Solutions for Up to $850K, Bolstering Functional Graphene Products and US Market Presence
Proactive Investors Australia Overview Australia's First Graphene has signed an agreement to acquire the assets, intellectual property, product lines, and manufacturing capabilities of US-based MITO Material Solutions for up to $850,000.... -
Cosmos Health Subsidiary Cana Laboratories Acquires International Patent WO2025108566A1, Expanding Nanotechnology Investment to Accelerate Next-Gen Healthcare Product Development
Stock Titan USA Overview Cosmos Health announced that its wholly-owned subsidiary, Cana Laboratories S.A., has acquired international patent application WO2025108566A1 from Cloudpharm P.C., significantly expanding its nanotechnology inve... -
Bioinspired Adiposomes Deliver Docetaxel to Lung, Multiple Myeloma, and Hepatocellular Carcinoma with Reduced Systemic Toxicity and Equivalent Efficacy
bioRxiv USA Overview Researchers have developed biocompatible adiposome nanoparticles for targeted delivery of the hydrophobic anticancer drug docetaxel (DTX), demonstrating significantly reduced systemic toxicity while maintaining equiv... -
CombiCult® Screening Platform Establishes Feeder-Free Bioreactor Scalability for iPSC-Derived NK Cell Manufacturing
Frontiers (Preprint) Germany Overview This preprint reports research developing a feeder-free protocol for generating mature, functional iPSC-derived natural killer (iNK) cells using the high-throughput combinatorial screening platform C... -
REPROCELL Develops Hypoimmune iPSC Engineering with AI-Designed CRISPR for Off-the-Shelf Cell Therapies
REPROCELL Japan Overview REPROCELL announced a method to develop hypoimmune iPSCs using AI-designed CRISPR, leveraging its StemEdit gene-editing platform. This approach targets key immune recognition genes like B2M and CIITA to create un... -
Human Continuum Closes Over $5 Million in Seed Round Funding to Advance Exosome-Based Therapeutic Longevity Platform Development
GlobeNewswire (Human Continuum Inc.) USA Overview Human Continuum Inc. successfully completed a $5.13 million seed funding round to accelerate the development of its exosome-based therapeutic and diagnostic platform across longevity, ort... -
Novartis and Orionis Biosciences Enter Strategic Collaboration for Molecular Glue Discovery in Up to $1.4 Billion Deal
BioBucks Biotech BD&L Tracker USA Overview Novartis announced a strategic collaboration with Orionis Biosciences to leverage Orionis' AI-driven "Allo-Glue™" platform across multiple challenging therapeutic targets. The deal includes a $4... -
AmMax Bio Licenses Lonza’s Conjugation and Linker-Payload Technologies for ADC Program AMB-104
The Pharma Letter USA Overview AmMax Bio announced a non-exclusive licensing agreement with Lonza, a leading CDMO, to utilize Lonza's conjugation and linker-payload technologies. This collaboration aims to support the development of AmMa...
